Global Parkinson’s Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Parkinson’s Disease Treatment Market Overview

• 1.1 Product Overview and Scope of Parkinson’s Disease Treatment
• 1.2 Classification of Parkinson’s Disease Treatment by Types
  • 1.2.1 Global Parkinson’s Disease Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Oral
  • 1.2.4 Transdermal
  • 1.2.5 Subcutaneous
  • 1.2.6 Intestinal Infusion
• 1.3 Global Parkinson’s Disease Treatment Market by Application
  • 1.3.1 Global Parkinson’s Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital Pharmacy
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Online Pharmacy
• 1.4 Global Parkinson’s Disease Treatment Market by Regions
  • 1.4.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Parkinson’s Disease Treatment (2014-2024)

2 Company Profiles

• 2.1 UCB
  • 2.1.1 Business Overview
  • 2.1.2 Parkinson’s Disease Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 AbbVie
  • 2.2.1 Business Overview
  • 2.2.2 Parkinson’s Disease Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Acorda Therapeutics
  • 2.3.1 Business Overview
  • 2.3.2 Parkinson’s Disease Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Roche
  • 2.4.1 Business Overview
  • 2.4.2 Parkinson’s Disease Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Teva
  • 2.5.1 Business Overview
  • 2.5.2 Parkinson’s Disease Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Prothena
  • 2.6.1 Business Overview
  • 2.6.2 Parkinson’s Disease Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Orion Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Parkinson’s Disease Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Impax Pharmaceuticals
  • 2.8.1 Business Overview
  • 2.8.2 Parkinson’s Disease Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Voyager Therapeutics
  • 2.9.1 Business Overview
  • 2.9.2 Parkinson’s Disease Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 MSD
  • 2.10.1 Business Overview
  • 2.10.2 Parkinson’s Disease Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Sunovion
  • 2.11.1 Business Overview
  • 2.11.2 Parkinson’s Disease Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Intec Pharma
  • 2.12.1 Business Overview
  • 2.12.2 Parkinson’s Disease Treatment Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 GSK
  • 2.13.1 Business Overview
  • 2.13.2 Parkinson’s Disease Treatment Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Acadia
  • 2.14.1 Business Overview
  • 2.14.2 Parkinson’s Disease Treatment Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 NeuroDerm
  • 2.15.1 Business Overview
  • 2.15.2 Parkinson’s Disease Treatment Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Adamas Therapeutics
  • 2.16.1 Business Overview
  • 2.16.2 Parkinson’s Disease Treatment Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Parkinson’s Disease Treatment Market Competition, by Players

• 3.1 Global Parkinson’s Disease Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Parkinson’s Disease Treatment Players Market Share
  • 3.2.2 Top 10 Parkinson’s Disease Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Parkinson’s Disease Treatment Market Size by Regions

• 4.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions
• 4.2 North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

5 North America Parkinson’s Disease Treatment Revenue by Countries

• 5.1 North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
• 5.2 USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

6 Europe Parkinson’s Disease Treatment Revenue by Countries

• 6.1 Europe Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries

• 7.1 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
• 7.2 China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

8 South America Parkinson’s Disease Treatment Revenue by Countries

• 8.1 South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Parkinson’s Disease Treatment by Countries

• 9.1 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

10 Global Parkinson’s Disease Treatment Market Segment by Type

• 10.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Parkinson’s Disease Treatment Market Forecast by Type (2019-2024)
• 10.3 Oral Revenue Growth Rate (2014-2024)
• 10.4 Transdermal Revenue Growth Rate (2014-2024)
• 10.5 Subcutaneous Revenue Growth Rate (2014-2024)
• 10.6 Intestinal Infusion Revenue Growth Rate (2014-2024)

11 Global Parkinson’s Disease Treatment Market Segment by Application

• 11.1 Global Parkinson’s Disease Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Parkinson’s Disease Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospital Pharmacy Revenue Growth (2014-2019)
• 11.4 Retail Pharmacy Revenue Growth (2014-2019)
• 11.5 Online Pharmacy Revenue Growth (2014-2019)

12 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)

• 12.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
• 12.2 Global Parkinson’s Disease Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology